Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23.

Morishima N, Mizoguchi I, Takeda K, Mizuguchi J, Yoshimoto T.

Biochem Biophys Res Commun. 2009 Aug 14;386(1):105-10. doi: 10.1016/j.bbrc.2009.05.140. Epub 2009 Jun 6.

PMID:
19501566
2.

Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity.

Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, McManus MT, Bluestone JA.

J Exp Med. 2008 Sep 1;205(9):1983-91. doi: 10.1084/jem.20080707. Epub 2008 Aug 25.

3.

Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity.

Glinka Y, Prud'homme GJ.

J Leukoc Biol. 2008 Jul;84(1):302-10. doi: 10.1189/jlb.0208090. Epub 2008 Apr 24.

4.

Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition.

Sarris M, Andersen KG, Randow F, Mayr L, Betz AG.

Immunity. 2008 Mar;28(3):402-13. doi: 10.1016/j.immuni.2008.01.012. Epub 2008 Mar 6.

5.

Plexin-A4 negatively regulates T lymphocyte responses.

Yamamoto M, Suzuki K, Okuno T, Ogata T, Takegahara N, Takamatsu H, Mizui M, Taniguchi M, Chédotal A, Suto F, Fujisawa H, Kumanogoh A, Kikutani H.

Int Immunol. 2008 Mar;20(3):413-20. doi: 10.1093/intimm/dxn006. Epub 2008 Jan 21.

PMID:
18209113
6.

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, Cua DJ.

Nat Immunol. 2007 Dec;8(12):1390-7. Epub 2007 Nov 11.

PMID:
17994024
7.

Recent advances in genetic analysis of multiple sclerosis: genetic associations and therapeutic implications.

Niino M, Fukazawa T, Kikuchi S, Sasaki H.

Expert Rev Neurother. 2007 Sep;7(9):1175-88. Review.

PMID:
17868016
8.

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors.

Ascherio A, Munger KL.

Ann Neurol. 2007 Jun;61(6):504-13. Review.

PMID:
17492755
9.

Neuropilin 1 and CD25 co-regulation during early murine thymic differentiation.

Corbel C, Lemarchandel V, Thomas-Vaslin V, Pelus AS, Agboton C, Roméo PH.

Dev Comp Immunol. 2007;31(11):1082-94. Epub 2007 Mar 2.

PMID:
17374393
11.

Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.

Veldhoen M, Hocking RJ, Flavell RA, Stockinger B.

Nat Immunol. 2006 Nov;7(11):1151-6. Epub 2006 Sep 24.

PMID:
16998492
12.

Semaphorin 7A is a negative regulator of T cell responses.

Czopik AK, Bynoe MS, Palm N, Raine CS, Medzhitov R.

Immunity. 2006 May;24(5):591-600.

13.

Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells.

Huber S, Schramm C, Lehr HA, Mann A, Schmitt S, Becker C, Protschka M, Galle PR, Neurath MF, Blessing M.

J Immunol. 2004 Dec 1;173(11):6526-31.

14.

Regulatory T cells: friend or foe in immunity to infection?

Mills KH.

Nat Rev Immunol. 2004 Nov;4(11):841-55. Review.

PMID:
15516964
15.

TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors.

Fu S, Zhang N, Yopp AC, Chen D, Mao M, Chen D, Zhang H, Ding Y, Bromberg JS.

Am J Transplant. 2004 Oct;4(10):1614-27.

16.

Semaphorins: mediators of repulsive growth cone guidance.

Kolodkin AL.

Trends Cell Biol. 1996 Jan;6(1):15-22.

PMID:
15157527
17.

Neuropilin-1: a surface marker of regulatory T cells.

Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, von Boehmer H, Buer J, Hansen W.

Eur J Immunol. 2004 Mar;34(3):623-630. doi: 10.1002/eji.200324799. Erratum in: Eur J Immunol. 2004 May;34(5):1498.

18.
19.

Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development.

Gu C, Rodriguez ER, Reimert DV, Shu T, Fritzsch B, Richards LJ, Kolodkin AL, Ginty DD.

Dev Cell. 2003 Jul;5(1):45-57.

20.

Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK.

J Exp Med. 2003 May 5;197(9):1073-81.

Supplemental Content

Support Center